Back
Verve Therapeutics Stock Predictions
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.
Sell
49
VERV
Verve Therapeutics
Last Price:
7.40
Seasonality Move:
-23.06%
7 Day Trial
ALL ACCESS PASS
$
7
Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street
See the remarkable discovery.Verve Therapeutics Stock Forecast
- Over the next 52 weeks, Verve Therapeutics has on average historically fallen by 46.3% based on the past 3 years of stock performance.
- Verve Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Verve Therapeutics Stock Undervalued?
The current Verve Therapeutics [VERV] share price is $7.48. The Score for VERV is 49, which is 2% below its historic median score of 50, and infers higher risk than normal. - VERV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Verve Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Verve Therapeutics has on average historically fallen by 46.3% based on the past 3 years of stock performance.
Verve Therapeutics Stock Rating
Sell
49
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics overpriced?
- Verve Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Verve Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vervetx.com
52-Week Data
52-Week High:
20.98
52-Week Low:
4.59
Prediction Charts
Market Cap:
628.06M
Price in USD:
7.48
Volume:
1.14M
Beta:
1.88
Technical Analysis
SMA50:
5.80
SMA100:
7.77
SMA200:
10.21
52-Wk Change:
-63.93%
Stock Predictions
-
Is Verve Therapeutics stock public?
Yes, Verve Therapeutics is a publicly traded company. -
What is the Verve Therapeutics stock quote today?
The Verve Therapeutics stock price is 7.48 USD today. -
How to buy Verve Therapeutics stock online?
You can buy Verve Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jul-8 | 5.30 | 5.67 | 5.75 | 5.26 |
| Jul-9 | 5.65 | 6.28 | 6.49 | 5.57 |
| Jul-10 | 6.31 | 6.05 | 6.41 | 5.94 |
| Jul-11 | 6.30 | 6.36 | 6.69 | 6.30 |
| Jul-12 | 6.48 | 6.72 | 7.15 | 6.38 |
| Jul-15 | 6.75 | 7.15 | 7.29 | 6.63 |
| Jul-16 | 7.28 | 7.86 | 7.96 | 7.18 |
| Jul-17 | 7.61 | 7.51 | 7.75 | 7.27 |
| Jul-18 | 7.52 | 6.82 | 7.52 | 6.60 |
| Jul-19 | 6.83 | 6.89 | 7.06 | 6.69 |
| Jul-22 | 6.99 | 7.18 | 7.19 | 6.76 |
| Jul-23 | 7.12 | 7.70 | 7.78 | 7.02 |
| Jul-24 | 7.68 | 7.08 | 7.69 | 7.08 |
| Jul-25 | 7.12 | 7.48 | 7.85 | 7.02 |
Verve Therapeutics Earnings
Verve Therapeutics Earnings Report: Per Share Verve Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Verve Therapeutics Forecast Revenue Growth
Verve Therapeutics Stock Analysis: Historical quarterly revenues per share for Verve Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.64 per share, and a decrease next year of $0.25 per share.
* Verve Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.